Journal article icon

Journal article

Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study

Abstract:
Evidence on the economic impact of novel skin tests for tuberculosis infection (TBST) is scarce and limited by study quality. We used estimates on the cost-effectiveness of the use of TBST compared to current tuberculosis infection (TBI) tests to assess whether TBST are affordable and feasible to implement under different country contexts. A Markov model parametrised to Brazil, South Africa and the UK was developed to compare the cost-effectiveness of three TBI testing strategies: (1) Diaskintest (DST), (2) TST test, and (3) IGRA QFT test. Univariate and probabilistic sensitivity analyses over unit costs and main parameters were performed. Our modelling results show that Diaskintest saves $5.60 and gains 0.024 QALYs per patient and $8.40, and 0.01 QALYs per patient in Brazil, compared to TST and IGRA respectively. In South Africa, Diaskintest is also cost-saving at $4.39, with 0.015 QALYs per patient gained, compared to TST, and $64.41, and 0.007 QALYs per patient, compared to IGRA. In the UK, Diaskintest saves $73.33, and gaines 0.0351 QALYs per patient, compared to TST. However, Diaskintest, compared to IGRA, showed an incremental cost of $521.45 (95% CI (500.94-545.07)) per QALY, below the willingness-to-pay threshold of $20.223 per QALY. Diaskintest potentially saves costs and results in greater health gains than the TST and IGRA tests in Brazil and South Africa. In the UK Diaskintest would gain health but also be more costly. Our results have potential external validity because TBST remained cost-effective despite extensive sensitivity analyses
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1371/journal.pgph.0002573

Authors

More by this author
Role:
Author
ORCID:
0000-0003-2392-6271
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-2144-7181
More by this author
Role:
Author
ORCID:
0000-0002-9845-4267
More by this author
Role:
Author
ORCID:
0000-0003-4086-114X
More by this author
Role:
Author
ORCID:
0000-0001-7696-3776


More from this funder
Funder identifier:
10.13039/100004423


Publisher:
Public Library of Science
Journal:
PLOS Global Public Health More from this journal
Volume:
3
Issue:
12
Pages:
e0002573-e0002573
Publication date:
2023-12-20
DOI:
EISSN:
2767-3375
ISSN:
2767-3375


Language:
English
Keywords:
Pubs id:
1991725
Local pid:
pubs:1991725
Source identifiers:
W4389990492
Deposit date:
2026-06-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP